Light VisionInc

What precautions should I be aware of? The safety and effectiveness of the LAL and LDD have not been established in patients with certain preexisting eye conditions or in patients who experience certain complications during cataract surgery. The safety and effectiveness of the LAL+ has not been substantiated in clinical trials. The effect of the LAL+ optical design on quality of vision, contrast sensitivity, and subjective visual disturbances have not been evaluated clinically. You should discuss these issues with your doctor.

LightBoxVision

This homogeneous backlight is ideal for inspecting and measuring outlines. The lateral coupling of the LED light ensures a very homogeneous radiation over the surface, which increases the quality of the test result. The MBJ backlight is characterized by its very compact format with a low height of only 12 mm.

Heatvision

White, red and infrared are usually delivered within 10 working days after receipt of order. For green, blue and yellow please contact our sales team for the delivery time.

Flex Series For special light dimensions, also take a look at our Flex series. With the Flex series, you can freely select the lengths and widths of the illuminated area in 100mm increments. You need special lighting with other dimensions or LED colors? No problem, please contact our sales department for an individual solution.

Who should not receive this treatment? The LAL/LAL+ and LDD system should not be used if you are taking medications that may increase your sensitivity to ultraviolet (UV) light; if you are taking a medication that is considered harmful to your retina; if you have a history of herpes eye infection or uncontrollable eye movements (nystagmus); or if you are unable to comply with your doctor’s schedule of LDD light treatments and instructions for wearing special UV-protective glasses for several weeks following cataract surgery.

Since the LAL is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

Light VisionGenshin

Size can be scaled in increments of 100 mm in width and length up to a maximum size of 800 mm x 1000 mm.  Choose from three standard colors - other LED wavelengths are available upon request.

Light visioneye

The data sheet contains an example of the suitable configuration via connection with the MBJ controller CTR-50 for continuous light operation.

The Flex Backlight is an indirect, diffuse lighting. This produces a homogeneous, diffuse light that is particularly suitable for assessing and measuring outlines.

Following surgery, you must wear the special UV-protective glasses during all waking hours for about 4 to 5 weeks and comply with your doctor’s schedule of LDD light treatments. Failure to wear the UV-protective glasses can result in an unpredicted vision change or loss of vision quality after exposure to UV light, such as from sunlight. This may require a second surgery to remove the LAL/LAL+ from your eye and replace it with another IOL.

Light Visionsuperpower

Approved use: The Light Adjustable Lens™ (LAL™), Light Adjustable Lens+™ (LAL+®), and Light Delivery Device™ (LDD™) system is approved for patients who have a cataract and need surgery for it, have corneal astigmatism (at least 0.75 diopters) before surgery, and do not have preexisting macular disease.

Light visionmeaning

What are the potential risks? As with any surgical procedure, there are risks associated with cataract surgery and IOL implantation. Please discuss these risks with your doctor. Potential risks associated with LDD light treatments include mild alterations to color perceptions; temporary scratchiness, irritation, or dryness to the front part of your eye; and activation of a previously undiagnosed herpes eye infection. Longer lasting and serious adverse events related to the UV light exposure are possible, but rare. There is a small chance that your vision could be made worse or that you may require additional surgery as a result of a complication.

Each Flex light is individual and will be manufactured only for you. Reorders can be made easily via your own article number.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

What warnings should I be aware of? Preexisting macular disease and certain eye conditions may increase the risk of complications. Your doctor will determine if you are a good candidate for the LAL/LAL+. If you have any complications during your cataract surgery before the LAL/LAL+ is implanted, you may need to have another intraocular lens (IOL) implanted instead of the LAL/LAL+.